Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Medigus Announces Polyrizon Signs Binding Collaboration Agreement With NurExone Biologic For Intranasal Administration Of Therapy For Spinal Cord Injuries, Polyrizon Is Entitled For Up to $3.35M Plus Future Royalties; Medigus Owns 37.03% Of Polyrizon

 Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Polyrizon Ltd.

MDGS